Glen Kristiansen

发表

Pathologist-Level Grading of Prostate Biopsies with Artificial Intelligence pdf

Ming Zhou, Toyonori Tsuzuki, Pekka Ruusuvuori, 2019, ArXiv.

Prostate malignancy grading using gland-related shape descriptors

Markus Löffler, Ulf-Dietrich Braumann, Patrick Scheibe, 2014, Medical Imaging.

High-accuracy prostate cancer pathology using deep learning

Yuri Tolkach, Glen Kristiansen, Tilmann Dohmgörgen, 2020, Nature Machine Intelligence.

Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes

Michael Schroeder, Christof Winter, Markus W. Büchler, 2012, PLoS Comput. Biol..

An artificial neural network considerably improves the diagnostic power of percent free prostate‐specific antigen in prostate cancer diagnosis: Results of a 5‐year investigation

Dietmar Schnorr, Steffen Hauptmann, Klaus Jung, 2002, International journal of cancer.

Quantitative Determination of Estrogen Receptor, Progesterone Receptor, and HER2 mRNA in Formalin-fixed Paraffin-embedded Tissue—A New Option for Predictive Biomarker Assessment in Breast Cancer

Carsten Denkert, Wilko Weichert, Manfred Dietel, 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.

Kurt Miller, Klaus Jung, Carsten Stephan, 2011, The Journal of urology.

Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.

Klaus Jung, Arndt Hartmann, Axel Semjonow, 2007, The Journal of urology.

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival

Christian Pilarsky, Stefan Roepcke, Bernd Hinzmann, 2005, The Journal of pathology.

WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer

Christian Pilarsky, Stefan Roepcke, Arndt Hartmann, 2003, The Journal of pathology.

ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.

Irina Klaman, Bernd Hinzmann, Glen Kristiansen, 2004, Cancer letters.

Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading

Andrew J. Evans, Lars Egevad, Matthias Schwenkglenks, 2011, Virchows Archiv.

Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

Iver Petersen, Glen Kristiansen, Thomas Knösel, 2003, The Journal of pathology.

Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?

Andreas Nitsche, Klaus Jung, Chuanliang Xu, 2005, Journal of Molecular Medicine.

Peroxisome Proliferator-Activated Receptor γ Is Highly Expressed in Pancreatic Cancer and Is Associated With Shorter Overall Survival Times

Peter Neuhaus, Christian Pilarsky, Robert Grützmann, 2006, Clinical Cancer Research.

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

Hans Lehrach, Klaus Jung, Christian Pilarsky, 2009, Journal of cellular and molecular medicine.

Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer

Christian Pilarsky, Irina Klaman, Bernd Hinzmann, 2006, Clinical Cancer Research.

Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue

Glen Kristiansen, Menelaos Zafrakas, Ruth Knüchel, 2006, International journal of cancer.

Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas

Holger Moch, Nicole Probst-Hensch, Alex Soltermann, 2010, Histopathology.

Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis

Arndt Hartmann, Peter J Wild, Glen Kristiansen, 2008, BMC Cancer.

Mining Tissue Microarray Data to Uncover Combinations of Biomarker Expression Patterns that Improve Intermediate Staging and Grading of Clear Cell Renal Cell Cancer

Peter Bühlmann, Holger Moch, Peter Schraml, 2009, Clinical Cancer Research.

Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.

Irina Klaman, Arndt Hartmann, Peter J Wild, 2004, International journal of oncology.

Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer

Klaus Jung, George M Yousef, Carsten Stephan, 2006, International journal of urology : official journal of the Japanese Urological Association.

CD24 is an effector of HIF-1-driven primary tumor growth and metastasis.

Glen Kristiansen, Dan Theodorescu, H. Frierson, 2012, Cancer research.

Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies

Florian Fritzsche, Glen Kristiansen, Menelaos Zafrakas, 2006, BMC Cancer.

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

Peter A Fasching, Arndt Hartmann, Matthias W Beckmann, 2008, Breast Cancer Research.

Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis

Volker Roth, Thomas J. Fuchs, Joachim M Buhmann, 2009, Cancer Epidemiology Biomarkers & Prevention.